Brief: Olema Oncology Q3 Net Income USD -34.555 Million
12/11/2024 21:01
Nov 12 (Reuters) - Olema Oncology Q3 basic EPS USD -0.6 vs. IBES estimate USD -0.58. * Q3 income from operations USD -37.621 million * Q3 operating expenses USD 37.621 million
Recent news on Olema Oncology
See all newsBrief: Olema Pharmaceuticals Changes Corporate Name To Olema Oncology, Effective Today
Olema Pharmaceuticals, Inc. reports results for the quarter ended September 30 - Earnings Summary
Olema Pharma Q3 net loss widens on higher costs
Brief: Olema Pharmaceuticals Q3 Net Income USD -73.599 Million
Olema Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary